Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2012

Open Access 01-12-2012 | Research

The prognostic value of a normal oral glucose tolerance test in pregnant women who tested positive at screening: a validation study

Authors: Patricia M Rehder, Belmiro G Pereira, João Luiz Pinto e Silva

Published in: Diabetology & Metabolic Syndrome | Issue 1/2012

Login to get access

Abstract

Background

Controversies surround a diagnosis of gestational diabetes mellitus (GDM). The objective of this study was to evaluate the oral glucose tolerance test (OGTT) for the prediction of adverse gestational and perinatal outcomes in pregnant women with a positive screening test for diabetes mellitus and a negative diagnosis, i.e. a normal 3-hour OGTT.

Methods

This validation study evaluated 409 pregnant women who tested positive for diabetes mellitus at screening. Perinatal and maternal outcomes were considered. Sensitivity and specificity were calculated for each of the values of the OGTT as a diagnostic test, with the gold standard being perinatal outcome.

Results

The most frequent risk factors were obesity, arterial hypertension and advanced maternal age. The most common neonatal outcomes were large-for-gestational-age infants, Cesarean delivery and preterm birth. A fasting blood glucose level of 87 mg/dL was the most powerful predictor of adverse perinatal outcome.

Conclusions

At the cut-off level adopted by the American Diabetes Association, gestational OGTT was able to successfully identify in which pregnant women outcome would be unfavorable.
Appendix
Available only for authorised users
Literature
1.
go back to reference American Diabetes Association: Gestation diabetes mellitus. Diabetes Care. 2000, 23 (Suppl 1): 77-79. American Diabetes Association: Gestation diabetes mellitus. Diabetes Care. 2000, 23 (Suppl 1): 77-79.
2.
go back to reference O' Sullivan JB, Mahan CM: Criteria for the oral glucose tolerance test in pregnancy. Diabetes. 1964, 13: 278-285. O' Sullivan JB, Mahan CM: Criteria for the oral glucose tolerance test in pregnancy. Diabetes. 1964, 13: 278-285.
3.
go back to reference Carpenter MW, Coustan DR: Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982, 144: 768-773.PubMed Carpenter MW, Coustan DR: Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982, 144: 768-773.PubMed
4.
go back to reference American Diabetes Association: Diagnosis and classification of Diabetes Mellitus. Diabetes Care. 2010, 33 (Suppl 1): 62-69.CrossRef American Diabetes Association: Diagnosis and classification of Diabetes Mellitus. Diabetes Care. 2010, 33 (Suppl 1): 62-69.CrossRef
5.
go back to reference International Association of Diabetes and Pregnancy Study Groups Consensus Panel (IADPSG): International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010, 33: 676-682.CrossRef International Association of Diabetes and Pregnancy Study Groups Consensus Panel (IADPSG): International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010, 33: 676-682.CrossRef
6.
go back to reference Negrato CA, Jovanovic L, Rafacho A, Tambascia MA, Geloneze B, Dias A, Rudge MVC: Association between different levels of dysglycemia and metabolic syndrome in pregnancy. Diabetol Metab Syndr. 2010, 1: 1-6. Negrato CA, Jovanovic L, Rafacho A, Tambascia MA, Geloneze B, Dias A, Rudge MVC: Association between different levels of dysglycemia and metabolic syndrome in pregnancy. Diabetol Metab Syndr. 2010, 1: 1-6.
7.
go back to reference Melo ASO, Assunção PL, Gondim SSR, Carvalho DF, Amorim MMR, Benício MHA, Cardoso MAA: Maternal nutritional status, gestational weight gain and birth weight. Rev Bras Epid. 2007, 10: 249-257. Melo ASO, Assunção PL, Gondim SSR, Carvalho DF, Amorim MMR, Benício MHA, Cardoso MAA: Maternal nutritional status, gestational weight gain and birth weight. Rev Bras Epid. 2007, 10: 249-257.
9.
go back to reference Torloni MR, Betrán AP, Nakamura MU, Atallah AN, Moron AF, Valente O: Pregnancy BMI and risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev. 2008, 10: 194-203.CrossRefPubMed Torloni MR, Betrán AP, Nakamura MU, Atallah AN, Moron AF, Valente O: Pregnancy BMI and risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev. 2008, 10: 194-203.CrossRefPubMed
10.
go back to reference International Diabetes Federation Clinical Guidelines Task Force: Global Guideline on Pregnancy and Diabetes. 2009, Brussels: International Diabetes Federation International Diabetes Federation Clinical Guidelines Task Force: Global Guideline on Pregnancy and Diabetes. 2009, Brussels: International Diabetes Federation
11.
go back to reference Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, Dyer AR, Leiva A, Hod M, Kitzmiler JL, Lowe LP, McIntyre HD, Oats JJ, Omori Y, Schmidt MI: International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010, 33: 676-682.CrossRefPubMed Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, Dyer AR, Leiva A, Hod M, Kitzmiler JL, Lowe LP, McIntyre HD, Oats JJ, Omori Y, Schmidt MI: International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010, 33: 676-682.CrossRefPubMed
12.
go back to reference Ferrara A, Weiss NS, Hedderson MM, Quesenberry CP, Selby JV, Ergas IJ, Peng T, Escobar GJ, Pettitt DJ, Sacks DA: Pregnancy plasma glucose levels exceeding the American Diabetes Association thresholds, but below the National Diabetes Data Group thresholds for gestational diabetes mellitus, are related to the risk of neonatal macrossomia, hypoglycemia and hyperbilirubinemia. Diabetologia. 2007, 50: 298-306. 10.1007/s00125-006-0517-8.CrossRefPubMed Ferrara A, Weiss NS, Hedderson MM, Quesenberry CP, Selby JV, Ergas IJ, Peng T, Escobar GJ, Pettitt DJ, Sacks DA: Pregnancy plasma glucose levels exceeding the American Diabetes Association thresholds, but below the National Diabetes Data Group thresholds for gestational diabetes mellitus, are related to the risk of neonatal macrossomia, hypoglycemia and hyperbilirubinemia. Diabetologia. 2007, 50: 298-306. 10.1007/s00125-006-0517-8.CrossRefPubMed
13.
go back to reference Agarwal MM, Dhatt GS, Othman Y, Gupta R: Gestational diabetes: fasting capillary glucose as a screening test in a multi-ethnic, high-risk population. Diabetic Med. 2009, 26: 760-765. 10.1111/j.1464-5491.2009.02765.x.CrossRefPubMed Agarwal MM, Dhatt GS, Othman Y, Gupta R: Gestational diabetes: fasting capillary glucose as a screening test in a multi-ethnic, high-risk population. Diabetic Med. 2009, 26: 760-765. 10.1111/j.1464-5491.2009.02765.x.CrossRefPubMed
14.
go back to reference HAPO Study Cooperative Research Group, Nesbitt GS, Smye M, Sheridan B, Lappin TR, Trimble ER: Integration of local and central laboratory functions in a worldwide multicentre study: experience from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Clin Trials. 2006, 3: 397-407. HAPO Study Cooperative Research Group, Nesbitt GS, Smye M, Sheridan B, Lappin TR, Trimble ER: Integration of local and central laboratory functions in a worldwide multicentre study: experience from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Clin Trials. 2006, 3: 397-407.
15.
go back to reference Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, Wapner RJ, Varner MW, Rouse DJ, Thorp JM, Sciscione A, Catalano P, Harper M, Saade G, Lain KY, Sorokin Y, Peaceman AM, Tolosa JE, Anderson GB, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network: A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl Med. 2009, 361: 1339-1348. 10.1056/NEJMoa0902430.CrossRef Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, Wapner RJ, Varner MW, Rouse DJ, Thorp JM, Sciscione A, Catalano P, Harper M, Saade G, Lain KY, Sorokin Y, Peaceman AM, Tolosa JE, Anderson GB, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network: A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl Med. 2009, 361: 1339-1348. 10.1056/NEJMoa0902430.CrossRef
16.
go back to reference HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA: Hyperglycemia and Adverse Pregnancy Outcomes (HAPO Study). N Engl J Med. 2008, 358: 1991-2002.CrossRef HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA: Hyperglycemia and Adverse Pregnancy Outcomes (HAPO Study). N Engl J Med. 2008, 358: 1991-2002.CrossRef
Metadata
Title
The prognostic value of a normal oral glucose tolerance test in pregnant women who tested positive at screening: a validation study
Authors
Patricia M Rehder
Belmiro G Pereira
João Luiz Pinto e Silva
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2012
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-4-10

Other articles of this Issue 1/2012

Diabetology & Metabolic Syndrome 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine